Opinion | Debating Mifepristone: Safety, Access and Risk
Source: WSJ.com : U.S. News · Bias: Center
Summary
Readers share different viewpoints on the abortion drug.
Related Coverage
- Some Thoughts on the Court's Opinion(s) in the Birthright Citizenship Case (Center Right — Reason.com)
- Will Trump v. Barbara End the Birthright Citizenship Debate? (UPDATED) (Center Right — Reason.com)
- Exes Lena Dunham and Jack Antonoff risk awkward run-in at Taylor Swift’s wedding festivities (Right — New York Post)
- Opinion | A (Mostly) Happy 250th American Birthday (Center — WSJ.com : U.S. News)
- Opinion | The Supreme Court’s Constitutional Restoration (Center — WSJ.com : U.S. News)
- Opinion | Todd Blanche Affirms the President’s Conduct (Center — WSJ.com : U.S. News)
- US moves to eliminate long-time radiation safety principle for nuclear power (Center — The Hill News)
- What to know about fireworks and the risk of wildfires this July 4 (Right — New York Post)
Daily Analysis
Read the full Parallax Pulse for May 11, 2026 — an AI-powered analysis of how Left and Right media covered the biggest stories this day.
More Headlines From May 11, 2026
- This week on the hill: Congress returns from recess facing high-stakes fights (Center)
- Trump vows to pause federal gas tax after Iran war boosts US fuel prices to four-year high (Center Left)
- Trump weighs military action against Iran with ceasefire "on life support" (Center Left)
- White House ballroom funds hang over GOP push to fund ICE (Center)
- Transcript: Trump Blurts Out Plot to Rig Midterms as Polls Turn Brutal (Left)
